| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University (S.S.H., B.D.-H.), Boston, Massachusetts 02111; and Department of Preventive Medicine, Carney Hospital (E.S., J.A.S.C., S.M.), Boston, Massachusetts 02124
Address all correspondence and requests for reprints to: Susan S. Harris, D.Sc., Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, 711 Washington Street, Boston, Massachusetts 02111.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Low vitamin D intakes and blood levels of 25-hydroxyvitamin D (25OHD), the metabolite that best reflects vitamin D status, are clearly linked to bone loss (14) and fracture (15, 16), and there is more limited evidence that vitamin D reduces the risk of hypertension (17, 18), cardiovascular disease (19), diabetes (19), and some cancers (20, 21). Vitamin D deficiency can be reversed easily and inexpensively through vitamin D supplementation and exposure to UV light. The identification of at-risk subsets of the U.S population is necessary to design and target appropriate interventions that have the potential to reduce the incidence of common and debilitating chronic diseases.
This report examines the wintertime vitamin D and PTH status of participants in the Boston Low Income Elderly Osteoporosis Study (BLEOS) of noninstitutionalized low income elderly men and women living in subsidized housing in Boston, Massachusetts.
| Experimental Subjects |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
A measurement team, led by Dr. Soteriades, went to each of the 14 housing units on 1 or 2 mornings in February or March of 1999 and collected nonfasting blood samples; made physical measurements, including height and weight; and administered a questionnaire about health-related conditions and behaviors. Translators were available to assist non-English-speaking residents. Laboratory measurements were made in the USDA Human Nutrition Research Center on Aging Nutrition Evaluation Laboratory at Tufts University. Plasma 25OHD was measured by the competitive protein binding method of Chen et al. (22), without the optional chromatography step, and the intra- and interassay coefficients of variation (CVs) were 5.0% and 7.3%, respectively. The laboratory reference range for 25OHD is 20137 nmol/L. Serum intact PTH was measured with Allegro intact RIA kits from Nichols Institute Diagnostics (San Juan Capistrano, CA), and the intra- and interassay CVs were 5.6% and 6.6%. The reference range for PTH is 1.16.9 pmol/L. Serum total calcium was measured with a Nova 7 calcium analyzer (Nova Biochemical, Waltham MA), and the intra- and interassay CVs were 1.2% and 3.0%. The reference range for serum calcium is 2.082.56 nmol/L.
The questionnaire included questions related to vitamin D and calcium
intakes, medication use, southern travel, smoking, and demographics.
Variables describing vitamin D and calcium intakes were constructed
from responses to categorical questions about milk consumption,
consumption of other dairy products, and use of vitamin D (including
multivitamins) and calcium supplements. An 8-oz serving of milk
contains 100 IU vitamin D and 300 mg calcium. One serving of other
dairy products contains no vitamin D and 300 mg calcium. Total vitamin
D intake was defined as low (<8 oz/day of milk and no vitamin D
supplement use), medium (
8 oz/day of milk and/or less than daily
vitamin D supplement use), or high (daily vitamin D supplement use
regardless of milk intake). Similarly, total calcium intake was defined
as low (less than two servings per day of dairy products and no calcium
supplement use), medium (two or more servings per day of dairy products
and/or less than daily calcium supplement use), or high (daily calcium
supplement use regardless of dairy product intake). No information was
collected about nondairy, nonsupplement sources of calcium and vitamin
D or other nutrients.
Statistical analysis
Characteristics of black and white subjects were compared with
two-tailed t tests for two independent samples and with the
2 test for differences in proportion. Group
means were adjusted and compared with analysis of covariance (ANCOVA),
and possible interactions were investigated by including interaction
terms in the ANCOVA models. Linear associations were investigated and
described with Pearson correlation coefficients and multivariable
linear regression. ANCOVA and regression analyses were conducted with
the General Linear Models procedure (SPSS, Inc., Chicago,
IL). P < 0.05 was considered to indicate statistical
significance.
| Results |
|---|
|
|
|---|
The ages of the black and white subjects ranged from 64100 yr. On the
average, the women were older than the men (Table 1
; P < 0.02), but age
did not differ significantly by race. The characteristics of the 246
black and white nontraveling subjects are shown in Table 1
. As
expected, many white subjects (42%) and even more black subjects
(71%) had not graduated from high school. The majority of subjects
were nonsmokers, but smoking was more common in men than in women
(P < 0.01). About half of the subjects consumed less
than one glass of milk per day, and consumption of other dairy products
was also low. Reported milk consumption did not differ significantly by
race. Regular (daily) use of vitamin D supplements, predominantly
multivitamins, ranged from 15% in black men to 46% in white women and
was significantly more common in white than in black subjects. Some,
but not all, other measures of vitamin D and calcium-related intakes
also differed by race in men and/or women (Table 1
).
|
|
|
The association of higher vitamin D intakes with higher 25OHD
concentrations is shown in Fig. 2
and
demonstrates that the greatest differences occurred between the highest
intake category (defined by daily vitamin D supplement use) and the
lower two intake categories. In a further ANCOVA model, total vitamin D
intake was replaced with separate variables for milk consumption and
vitamin D supplement use, and both of these were independently
associated with 25OHD (P = 0.027 and P
< 0.001, respectively).
|
A total of 14 women and no men reported the use of prescription medications to treat osteoporosis in the past 3 months (6 black and 2 white women used hormone replacement therapy, 1 black and 4 white women used alendronate, and 1 white woman used calcitonin). Exclusion of these women had little effect on the estimated racial differences in 25OHD.
Mean PTH was significantly higher in black than in white subjects
(Table 2
) both before and after adjustment for covariates. Mean PTH
tended to be higher in the women than in the men (P =
0.095 for the group overall), but differences within race subsets were
not statistically significant. About 23% of the overall population had
PTH values above the reference range, and this percentage was 39% in
black men, 43% in black women, 13% in white men, and 22% in white
women. Serum calcium concentrations were normal in all but one of these
individuals, a black woman whose serum calcium concentration was just
over the upper normal limit.
PTH was inversely correlated with 25OHD in the group as a whole (r
= -0.30; P < 0.001), and this association is shown by
race in Fig. 3
(top). Although
higher 25OHD concentrations were associated with lower PTH
concentrations in both blacks and whites, blacks had higher PTH levels
at each 25OHD concentration. There was no evidence of a PTH plateau
with higher 25OHD in whites, and the apparent plateau in blacks is
based on only 12 subjects who had 25OHD concentrations as high as 75
nmol/L (compared with 33 whites). The association of 25OHD with PTH was
further examined in an ANCOVA model that included 25OHD, race, sex,
age, and calcium intake as independent variables. Predictors of higher
PTH included lower 25OHD (P < 0.001), black race
(P = 0.004), and higher age (P =
0.012).
|
Selected descriptive information for the two smaller race subsets of
the BLEOS population is shown in Table 3
.
Overall, mean 25OHD and PTH levels in these two groups were similar to
those in the white subjects. The small number of Asian women had
relatively low 25OHD and high PTH, perhaps because of their low vitamin
D and calcium intake. Forty-eight percent of the Hispanic and 50% of
the Asian subjects had 25OHD concentrations below 50 nmol/L.
|
| Discussion |
|---|
|
|
|---|
An optimal 25OHD concentration has also not been defined, but increases to 50 nmol/L or higher have been associated with increased suppression of PTH (24, 25) and reductions in bone loss and fracture (16). Too few of the BLEOS subjects had 25OHD concentrations sufficiently high to identify the point at which PTH concentrations are maximally suppressed. Although there does appear to be some leveling off between 50 and 75 nmol/L in black subjects, this apparent plateau is based on too few people to provide compelling evidence that 50 nmol/L is an optimal 25OHD concentration in blacks or that there is a racial difference in the plateau level. The BLEOS data do demonstrate that in terms of suppressing PTH, 25OHD concentrations of at least 50 nmol/L, if not higher, are desirable in both blacks and whites. Whereas 65% of whites achieved this concentration in winter, only 27% of black subjects did. Although only a small number of Hispanic and Asian subjects were studied, low 25OHD concentrations appear to be prevalent in these groups as well (48% of the Hispanics and 50% of the Asians).
This is the first study of vitamin D status in an exclusively low income population of elderly Americans. Although there may be other low income populations at higher risk, the mean wintertime vitamin D concentrations of the white men and women in BLEOS were about the same as those in the relatively affluent Framingham cohort (9) and in members of a Michigan health maintenance organization (12). Age over a range similar to that of the BLEOS subjects (64100 yr) has been reported by others to be associated with 25OHD concentrations (9), but we did not observe a similar association. This may result from the fact that age-related declines in skin synthesis of vitamin D (26) do not influence 25OHD concentrations in winter to the extent that they do in other seasons. Sex was also not a significant determinant of 25OHD concentrations in this study, and this is consistent with previous reports that at Bostons latitude, men have higher 25OHD concentrations in summer but not in winter (3, 9). Our finding of lower 25OHD concentrations in smokers is consistent with a previous report in humans (27) and may be an effect of nicotine (28).
Low 25OHD concentrations clearly contributed to reduced serum calcium and increased PTH in both blacks and whites and also explained some of the racial difference in PTH. Mean PTH concentrations of both young (5, 8) and older black adults (12, 29) have been reported to be higher than those of whites, and PTH increases more rapidly with age in black than in white adults (29). The parathyroid glands of healthy blacks are larger than those of healthy whites (30), and this difference is not explained by differences in body size. We have demonstrated that the PTH difference is not entirely due to differences in current vitamin D status, but our data do not provide an explanation for the residual difference. It may be due to a relatively lower skeletal sensitivity to the resorptive effects of PTH in blacks (5, 32, 33) or to racial differences in calcium and sodium intake and handling (29). Another interesting suggestion has been that long-term vitamin D deficiency may cause parathyroid hyperplasia that results in elevated PTH even after vitamin D status has been improved (34, 35). It will be important to test these theories because elevated PTH has been linked not only to bone loss, but also to hypertension, a condition that is highly prevalent in elderly blacks (36).
In conclusion, suboptimal vitamin D status is common in Bostons low income elderly. Although a problem in all race groups, it is most serious in African-Americans, 73% of whom were found to have low vitamin D concentrations in winter. Increased use of vitamin D supplements, fortified milk, and other foods can effectively improve wintertime vitamin D status in Northern areas and should be strongly promoted by clinicians, educators, and public health policymakers.
| Footnotes |
|---|
Received June 9, 2000.
Revised July 25, 2000.
Accepted August 1, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Wolf, J. Betancourt, Y. Chang, A. Shah, M. Teng, H. Tamez, O. Gutierrez, C. A. Camargo Jr., M. Melamed, K. Norris, et al. Impact of Activated Vitamin D and Race on Survival among Hemodialysis Patients J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1379 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Bowden, R. F. Robinson, R. Carr, and J. D. Mahan Prevalence of Vitamin D Deficiency and Insufficiency in Children With Osteopenia or Osteoporosis Referred to a Pediatric Metabolic Bone Clinic Pediatrics, June 1, 2008; 121(6): e1585 - e1590. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E Judd, M. S Nanes, T. R Ziegler, P. W. Wilson, and V. Tangpricha Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey Am. J. Clinical Nutrition, January 1, 2008; 87(1): 136 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Hannan, H. J. Litman, A. B. Araujo, C. E. McLennan, R. R. McLean, J. B. McKinlay, T. C. Chen, and M. F. Holick Serum 25-Hydroxyvitamin D and Bone Mineral Density in a Racially and Ethnically Diverse Group of Men J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 40 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A Talwar, J. F Aloia, S. Pollack, and J. K Yeh Dose response to vitamin D supplementation among postmenopausal African American women Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1657 - 1662. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Alpert and U. Shaikh The Effects of Vitamin D Deficiency and Insufficiency on the Endocrine and Paracrine Systems Biol Res Nurs, October 1, 2007; 9(2): 117 - 129. [Abstract] [PDF] |
||||
![]() |
E. Giovannucci, Y. Liu, and W. C. Willett Cancer Incidence and Mortality and Vitamin D in Black and White Male Health Professionals Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2467 - 2472. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F Aloia, S. A Talwar, S. Pollack, M. Feuerman, and J. K Yeh Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am. J. Clinical Nutrition, September 1, 2006; 84(3): 602 - 609. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Harris Vitamin D and African Americans J. Nutr., April 1, 2006; 136(4): 1126 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Calvo and S. J. Whiting Public Health Strategies to Overcome Barriers to Optimal Vitamin D Status in Populations with Special Needs J. Nutr., April 1, 2006; 136(4): 1135 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M Egan Commentary: Sunlight, vitamin D, and the cancer connection revisited Int. J. Epidemiol., April 1, 2006; 35(2): 227 - 230. [Full Text] [PDF] |
||||
![]() |
C. F. Garland, F. C. Garland, E. D. Gorham, M. Lipkin, H. Newmark, S. B. Mohr, and M. F. Holick The Role of Vitamin D in Cancer Prevention Am J Public Health, February 1, 2006; 96(2): 252 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Favus Postmenopausal Osteoporosis and the Detection of So-Called Secondary Causes of Low Bone Density J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3800 - 3801. [Full Text] [PDF] |
||||
![]() |
S. Levis, A. Gomez, C. Jimenez, L. Veras, F. Ma, S. Lai, B. Hollis, and B. A. Roos Vitamin D Deficiency and Seasonal Variation in an Adult South Florida Population J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1557 - 1562. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Hanley and K. S. Davison Vitamin D Insufficiency in North America J. Nutr., February 1, 2005; 135(2): 332 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dawson-Hughes Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1763S - 1766S. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A Bischoff-Ferrari, T. Dietrich, E J. Orav, F. B Hu, Y. Zhang, E. W Karlson, and B. Dawson-Hughes Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged >=60 y Am. J. Clinical Nutrition, September 1, 2004; 80(3): 752 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Gordon, K. C. DePeter, H. A. Feldman, E. Grace, and S. J. Emans Prevalence of Vitamin D Deficiency Among Healthy Adolescents Arch Pediatr Adolesc Med, June 1, 2004; 158(6): 531 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Breen and E. Shane Prolonged Hypocalcemia After Treatment With Zoledronic Acid in a Patient With Prostate Cancer and Vitamin D Deficiency J. Clin. Oncol., April 15, 2004; 22(8): 1531 - 1532. [Full Text] [PDF] |
||||
![]() |
F. Grados, M. Brazier, S. Kamel, M. Mathieu, N. Hurtebize, M. Maamer, M. Garabedian, J.-L. Sebert, and P. Fardellone Prediction of Bone Mass Density Variation by Bone Remodeling Markers in Postmenopausal Women with Vitamin D Insufficiency Treated with Calcium and Vitamin D Supplementation J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5175 - 5179. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. S. Barzel Recommended Testing in Patients with Low Bone Density J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1404 - 1405. [Full Text] |
||||
![]() |
R. Vieth, Y. Ladak, and P. G. Walfish Age-Related Changes in the 25-Hydroxyvitamin D Versus Parathyroid Hormone Relationship Suggest a Different Reason Why Older Adults Require More Vitamin D J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 185 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. H. de Boer, I. Gorodetskaya, B. Young, C.-y. Hsu, and G. M. Chertow The Severity of Secondary Hyperparathyroidism in Chronic Renal Insufficiency is GFR-Dependent, Race-Dependent, and Associated with Cardiovascular Disease J. Am. Soc. Nephrol., November 1, 2002; 13(11): 2762 - 2769. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Watson and C. E. Marx New Onset of Neuropsychiatric Symptoms in the Elderly: Possible Primary Hyperparathyroidism Psychosomatics, October 1, 2002; 43(5): 413 - 417. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F Holick Too little vitamin D in premenopausal women: why should we care? Am. J. Clinical Nutrition, July 1, 2002; 76(1): 3 - 4. [Full Text] [PDF] |
||||
![]() |
C. Valmadrid, C. Voorhees, B. Litt, and C. R. Schneyer Practice Patterns of Neurologists Regarding Bone and Mineral Effects of Antiepileptic Drug Therapy Arch Neurol, September 1, 2001; 58(9): 1369 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Harris, E. Soteriades, and B. Dawson-Hughes Secondary Hyperparathyroidism and Bone Turnover in Elderly Blacks and Whites J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3801 - 3804. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Souberbielle, C. Cormier, C. Kindermans, P. Gao, T. Cantor, F. Forette, and E. E. Baulieu Vitamin D Status and Redefining Serum Parathyroid Hormone Reference Range in the Elderly J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3086 - 3090. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||